Adma Biologics Inc organizacji Dochód

Jaka jest wartość Dochód organizacji Adma Biologics Inc?

Wartość Dochód organizacji Adma Biologics Inc to $330.244M

Jaka jest definicja Dochód?



Przychody (Revenue) jest przychodem, jaki firma osiąga z normalnej działalności gospodarczej, zwykle ze sprzedaży towarów i usług klientom.

Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.

In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.

Dochód firm w Health Care sektor na NASDAQ w porównaniu do Adma Biologics Inc

Czym się zajmuję organizacja Adma Biologics Inc?

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.

Firmy z dochód podobne do Adma Biologics Inc